How Northern Universities Are Partnering With NHS Trusts to Fuel Health Innovation

The Unlikely Rise of a Health Innovation Powerhouse

Huddersfield is not a name typically associated with cutting-edge medical research. The West Yorkshire town has long been defined by its industrial and manufacturing roots. Yet today, it stands as a compelling example of how strategic partnerships between universities, NHS trusts, and private businesses can transform regional economies and accelerate healthcare innovation.

At the heart of this transformation is the University of Huddersfield's National Health Innovation Campus — an ambitious, eco-conscious development designed to become one of the most forward-thinking health research environments in the country.

A Campus Built for the Future

Prof Liz Towns-Andrews, the driving force behind the campus, anticipates receiving approval next month for the third of seven planned eco-buildings earmarked for research and technology development near Huddersfield's town centre. This follows the opening in March of the £55 million Emily Siddon Centre — named after a local healthcare advocate — by the then health innovation minister, Zubir Ahmed.

The five-storey facility made headlines for housing the UK's first MRI scanner simulator: a machine that replicates the full experience of an MRI scan without the powerful magnets. "You genuinely wouldn't know it wasn't a fully operational machine," says the Yorkshire-born Towns-Andrews.

The campus also features Britain's first community diagnostic centre located on a university campus, developed alongside Calderdale and Huddersfield NHS Foundation Trust. All buildings have been constructed to meet rigorous environmental and wellbeing standards — known as the Well standard — placing them among the top 50 such facilities globally.

Addressing Productivity Through Health

One of Towns-Andrews's central ambitions is tackling the region's persistently low worker productivity. Yorkshire and Humberside consistently records some of England's lowest economic outputs per hour worked, making the case for health-led investment all the more urgent.

"It wasn't exactly a complex equation — helping people stay healthy and capable of working would have the single greatest impact on productivity," she explains.

The campus is funded through a blend of public and private finance, with regional institutions also capitalising on a share of the £2 billion West Yorkshire investment zone. Since opening in September 2023, the hub has already supported around 380 companies, with that figure continuing to climb.

A Model for Universities Under Financial Strain

The Huddersfield initiative arrives at a critical moment for British higher education. A recent report by the University of East London, which reviewed the financial accounts of 160 universities, found that nearly 40 institutions were approaching insolvency, with just two months of operating cash available. By contrast, Huddersfield recorded an operating surplus of approximately £10 million in the 2024–25 financial year.

With Oxford and Cambridge long established as magnets for biotech and medical spin-outs, universities in other regions are increasingly stepping up — building coalitions with health trusts and local councils to both drive research and support their surrounding economies.

"Combining the strengths of a council, a university, and a health trust gives you an extraordinarily powerful engine for economic growth," says Carson McCombe, head of innovation at the University of Huddersfield.

Manchester Joins the Innovation Wave

Huddersfield is far from alone. Manchester is set to benefit from the opening of a major research and development centre belonging to Convatec — a FTSE 100 healthcare company — which has positioned the city alongside Boston, Massachusetts, as one of its twin global R&D hubs. The company told shareholders that staff should be embedded in Manchester specifically to tap into the collaborative networks offered by the city's universities and NHS trusts.

The move reflects a broader trend. Prof Tony Young, NHS England's national clinical director for innovation, notes that geopolitical uncertainty — including the unpredictable business climate created by Donald Trump's administration — has encouraged US health companies to redirect investment toward the UK. He also credits Chancellor Rachel Reeves with prioritising biotech and health as cornerstones of the government's industrial strategy.

Young, who launched five companies while training as a urology surgeon two decades ago, recalls having to fight the healthcare system every step of the way. The landscape has changed considerably since then. "Today, the NHS functions as an integrator — bringing together Nobel laureates, clinicians, investors, and innovators within a collaborative ecosystem designed to bring bold ideas to life," he says.

Local Success Stories: Paxman Scalp Cooling

Just across the street from Huddersfield's Emily Siddon Centre sits a 125-year-old textile mill soon to be repurposed by Paxman Scalp Cooling — one of the town's fastest-growing businesses. The company produces a specialised head cap that prevents hair loss during chemotherapy treatment, a product now used by 97% of NHS trusts across the UK and distributed to hospitals in more than 50 countries. Over half of its exports go to the United States.

Richard Paxman, chief executive of the Stockholm-listed company and son of its founder, credits university and organisational partnerships with fuelling the company's innovation, expansion, and job creation over the years.

Challenges and Setbacks

Despite these encouraging developments, the Labour government has encountered significant stumbles in its efforts to engage the health industry. AstraZeneca, the UK's largest pharmaceutical company, scrapped a £450 million investment in its vaccine manufacturing plant in Speke, Merseyside, following a reduction in government financial support — a high-profile blow to the administration's ambitions.

Meanwhile, American technology firms Palantir and Epic Systems have secured substantial NHS contracts, with Epic opening a sprawling 36-hectare campus near Bristol to deliver its patient booking and records platform. Critics have raised questions about the transparency and circumstances surrounding these deals.

The Bigger Economic Picture

Despite these challenges, the strategic alliance between universities and health institutions is gaining recognition as a genuine driver of national prosperity. Universities UK, the sector's lobbying body, estimates that teaching, research, and innovation activities across UK higher education contribute £158 billion to the economy.

Research from the Federal Reserve Bank of Philadelphia reinforces this view on a global scale. A study examining the combined role of universities and hospitals in regional economies found that together, these institutions support 18 million jobs and generate more than £1 trillion in income in the United States alone — underscoring just how pivotal these anchor institutions have become to the modern economic landscape.

As Malcolm Press, president of Universities UK, puts it, the data is clear: universities and health trusts are no longer just places of learning and healing — they are engines of innovation, employment, and long-term economic resilience.